Cargando…

The using of a piglets as a model for evaluating the dipyrone hematological effects

BACKGROUND: Dipyrone (MET, metamizole) is a non-steroidal anti-inflammatory drug commonly used both in human and in veterinary medicine. After oral administration, is broken down rapidly to metabolites which largely retain the activity of the parent drug. Its metabolites have analgesic, antipyretic...

Descripción completa

Detalles Bibliográficos
Autores principales: Burmańczuk, Artur, Milczak, Andrzej, Grabowski, Tomasz, Osypiuk, Monika, Kowalski, Cezary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123311/
https://www.ncbi.nlm.nih.gov/pubmed/27884143
http://dx.doi.org/10.1186/s12917-016-0891-5
_version_ 1782469708148113408
author Burmańczuk, Artur
Milczak, Andrzej
Grabowski, Tomasz
Osypiuk, Monika
Kowalski, Cezary
author_facet Burmańczuk, Artur
Milczak, Andrzej
Grabowski, Tomasz
Osypiuk, Monika
Kowalski, Cezary
author_sort Burmańczuk, Artur
collection PubMed
description BACKGROUND: Dipyrone (MET, metamizole) is a non-steroidal anti-inflammatory drug commonly used both in human and in veterinary medicine. After oral administration, is broken down rapidly to metabolites which largely retain the activity of the parent drug. Its metabolites have analgesic, antipyretic and anti-inflammatory effects. RESULTS: The subjects were eight healthy male Large White post-suckling piglets, weighing between 5.0 to 7.4 kg, of ages 35 ± 10 days. The animals were administered MET (100 mg/kg) by an intramuscular (I.M.) injection. The study calculated the value of several hemorheological parameters. Significant impact of MET treatment (p < 0.05) was proven in case: activated partial thromboplastin time; ratio of activated partial thromboplastin time; hemoglobin; hematocrit; mean corpuscular hemoglobin; mean corpuscular volume; red blood cells volume; white blood cells volume; prothrombin time index. CONCLUSIONS: In summation, our observations suggest that a piglet model is useful for studying the impact of MET on hemorheological parameters. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12917-016-0891-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5123311
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51233112016-12-06 The using of a piglets as a model for evaluating the dipyrone hematological effects Burmańczuk, Artur Milczak, Andrzej Grabowski, Tomasz Osypiuk, Monika Kowalski, Cezary BMC Vet Res Research Article BACKGROUND: Dipyrone (MET, metamizole) is a non-steroidal anti-inflammatory drug commonly used both in human and in veterinary medicine. After oral administration, is broken down rapidly to metabolites which largely retain the activity of the parent drug. Its metabolites have analgesic, antipyretic and anti-inflammatory effects. RESULTS: The subjects were eight healthy male Large White post-suckling piglets, weighing between 5.0 to 7.4 kg, of ages 35 ± 10 days. The animals were administered MET (100 mg/kg) by an intramuscular (I.M.) injection. The study calculated the value of several hemorheological parameters. Significant impact of MET treatment (p < 0.05) was proven in case: activated partial thromboplastin time; ratio of activated partial thromboplastin time; hemoglobin; hematocrit; mean corpuscular hemoglobin; mean corpuscular volume; red blood cells volume; white blood cells volume; prothrombin time index. CONCLUSIONS: In summation, our observations suggest that a piglet model is useful for studying the impact of MET on hemorheological parameters. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12917-016-0891-5) contains supplementary material, which is available to authorized users. BioMed Central 2016-11-25 /pmc/articles/PMC5123311/ /pubmed/27884143 http://dx.doi.org/10.1186/s12917-016-0891-5 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Burmańczuk, Artur
Milczak, Andrzej
Grabowski, Tomasz
Osypiuk, Monika
Kowalski, Cezary
The using of a piglets as a model for evaluating the dipyrone hematological effects
title The using of a piglets as a model for evaluating the dipyrone hematological effects
title_full The using of a piglets as a model for evaluating the dipyrone hematological effects
title_fullStr The using of a piglets as a model for evaluating the dipyrone hematological effects
title_full_unstemmed The using of a piglets as a model for evaluating the dipyrone hematological effects
title_short The using of a piglets as a model for evaluating the dipyrone hematological effects
title_sort using of a piglets as a model for evaluating the dipyrone hematological effects
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123311/
https://www.ncbi.nlm.nih.gov/pubmed/27884143
http://dx.doi.org/10.1186/s12917-016-0891-5
work_keys_str_mv AT burmanczukartur theusingofapigletsasamodelforevaluatingthedipyronehematologicaleffects
AT milczakandrzej theusingofapigletsasamodelforevaluatingthedipyronehematologicaleffects
AT grabowskitomasz theusingofapigletsasamodelforevaluatingthedipyronehematologicaleffects
AT osypiukmonika theusingofapigletsasamodelforevaluatingthedipyronehematologicaleffects
AT kowalskicezary theusingofapigletsasamodelforevaluatingthedipyronehematologicaleffects
AT burmanczukartur usingofapigletsasamodelforevaluatingthedipyronehematologicaleffects
AT milczakandrzej usingofapigletsasamodelforevaluatingthedipyronehematologicaleffects
AT grabowskitomasz usingofapigletsasamodelforevaluatingthedipyronehematologicaleffects
AT osypiukmonika usingofapigletsasamodelforevaluatingthedipyronehematologicaleffects
AT kowalskicezary usingofapigletsasamodelforevaluatingthedipyronehematologicaleffects